摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2,5-Dioxopyrrolidin-1-yl)methyl 2-(acetyloxy)benzoate | 32620-72-7

中文名称
——
中文别名
——
英文名称
(2,5-Dioxopyrrolidin-1-yl)methyl 2-(acetyloxy)benzoate
英文别名
(2,5-dioxopyrrolidin-1-yl)methyl 2-acetyloxybenzoate
(2,5-Dioxopyrrolidin-1-yl)methyl 2-(acetyloxy)benzoate化学式
CAS
32620-72-7
化学式
C14H13NO6
mdl
——
分子量
291.26
InChiKey
LNIRSJVVXSYEBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    117.5°C
  • 沸点:
    433.27°C (rough estimate)
  • 密度:
    1.2974 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    90
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2,5-Dioxopyrrolidin-1-yl)methyl 2-(acetyloxy)benzoate 在 10 percent human plasma 作用下, 以 乙腈 为溶剂, 生成 、 阿司匹林
    参考文献:
    名称:
    评估阿司匹林的乙醇酰胺酯和其他各种酯类化合物是否为真正的阿司匹林前药。
    摘要:
    合成了一系列乙酰基水杨酸(阿司匹林)的乙醇酰胺,乙醇酸酯,(酰氧基)甲基,烷基和芳基酯,并将其评估为阿司匹林的潜在前药形式。N,N-二取代的乙醇酰胺酯被发现在人血浆中迅速水解,导致形成阿司匹林以及相应的水杨酸酯。这些反过来又迅速水解成水杨酸。在N,N-二甲基-和N,N-二乙基甘醇酰胺酯的情况下,由这些酯形成的最大量的阿司匹林分别为50和55%。用N,N-二甲基-和N,N-二乙基乙醇酰胺酯在血液中获得了相似的结果。未取代的和单取代的乙二酰胺酰胺酯以及大多数其他先前被认为是阿司匹林前体酯的酯已显示出仅水解为相应的水杨酸酯。测定了酯的亲脂性参数和水溶性,并讨论了有利于酯前药水解但以脱乙酰基为代价产生水杨酸酯的结构因素。关于阿司匹林的一些N,N-二取代的乙醇酰胺酯的特性,突出了它们作为潜在的阿司匹林前药的用途。
    DOI:
    10.1021/jm00123a040
  • 作为产物:
    描述:
    阿司匹林三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 生成 (2,5-Dioxopyrrolidin-1-yl)methyl 2-(acetyloxy)benzoate
    参考文献:
    名称:
    Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide- / isatin esters of some NSAIDs as prodrugs with an improved therapeutic index
    摘要:
    Ester prodrugs of aspirin 1a, ibuprofen 1b, naproxen 1c and indomethacin 1d were synthesized using N-Hydroxymethylsuccinimide (HMSI) 3 and N-hydroxymethylisatin (HMIS) 4 as promoieties to reduce their gastrointestinal toxicity and improve bioavailability. Additionally, the kinetics of hydrolysis of the synthesized prodrugs 5a-d and 6a-d were studied at 37 degrees C in non-enzymatic simulated gastric fluid (SGF; hydrochloric acid buffer pH = 1.2); 0.02 M phosphate buffer (pH = 7.4); 80% human plasma and 10% rat liver homogenate. The results indicate higher chemical stability of the ester prodrugs in non-enzymatic SGF (t(1/2) congruent to 6.5-18.6 h) and rapid conversion to the parent drugs in 80% human plasma (t1/2 congruent to 11.4-235 min) as well as in 10% rat liver homogenates (t(1/2) congruent to 12.0-90.0 min). As a general pattern, the HMSI esters 5a-d revealed higher chemical stability than the corresponding HMIS analogues 6a-d. The pH-rate profile of 5c and 6a indicated maximum stability of the former at pH = 1.2-8.0 and of the latter at pH = 1.2-4.0. The distribution coefficient (D-7.4) values of the prodrugs 5a-d, 6a-d and the parent drugs 1a-d in an n-octanol/phosphate buffer (pH =7.4) system indicated enhanced lipophilic properties of the prodrugs. Furthermore, the HMIS ester prodrugs 6a-d are more lipophilic than the corresponding HMSI derivatives 5a-d. In vivo ulcerogenicity studies using scanning electron microscopy on stomach specimens of rats treated with an oral dose for 4 d revealed that the synthesized ester prodrugs are significantly less irritating to gastric mucosa than the parent drugs. These results suggested HMSI and/or HMIS esters possess good potential as prodrugs with an improved therapeutic index for oral delivery of NSAIDs. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
    DOI:
    10.1016/s0223-5234(00)80025-2
点击查看最新优质反应信息

文献信息

  • Evaluation of glycolamide esters and various other esters of aspirin as true aspirin prodrugs
    作者:Niels Moerk Nielsen、Hans Bundgaard
    DOI:10.1021/jm00123a040
    日期:1989.3
    aryl esters of acetylsalicylic acid (aspirin) were synthesized and evaluated as potential prodrug forms of aspirin. N,N-Disubstituted glycolamide esters were found to be rapidly hydrolyzed in human plasma, resulting in the formation of aspirin as well as the corresponding salicylate esters. These in turn hydrolyzed rapidly to salicylic acid. The largest amount of aspirin formed from the esters were
    合成了一系列乙酰基水杨酸(阿司匹林)的乙醇酰胺,乙醇酸酯,(酰氧基)甲基,烷基和芳基酯,并将其评估为阿司匹林的潜在前药形式。N,N-二取代的乙醇酰胺酯被发现在人血浆中迅速水解,导致形成阿司匹林以及相应的水杨酸酯。这些反过来又迅速水解成水杨酸。在N,N-二甲基-和N,N-二乙基甘醇酰胺酯的情况下,由这些酯形成的最大量的阿司匹林分别为50和55%。用N,N-二甲基-和N,N-二乙基乙醇酰胺酯在血液中获得了相似的结果。未取代的和单取代的乙二酰胺酰胺酯以及大多数其他先前被认为是阿司匹林前体酯的酯已显示出仅水解为相应的水杨酸酯。测定了酯的亲脂性参数和水溶性,并讨论了有利于酯前药水解但以脱乙酰基为代价产生水杨酸酯的结构因素。关于阿司匹林的一些N,N-二取代的乙醇酰胺酯的特性,突出了它们作为潜在的阿司匹林前药的用途。
  • Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide- / isatin esters of some NSAIDs as prodrugs with an improved therapeutic index
    作者:Nadia M Mahfouz、Farghaly A Omar、Tarek Aboul-Fadl
    DOI:10.1016/s0223-5234(00)80025-2
    日期:1999.7
    Ester prodrugs of aspirin 1a, ibuprofen 1b, naproxen 1c and indomethacin 1d were synthesized using N-Hydroxymethylsuccinimide (HMSI) 3 and N-hydroxymethylisatin (HMIS) 4 as promoieties to reduce their gastrointestinal toxicity and improve bioavailability. Additionally, the kinetics of hydrolysis of the synthesized prodrugs 5a-d and 6a-d were studied at 37 degrees C in non-enzymatic simulated gastric fluid (SGF; hydrochloric acid buffer pH = 1.2); 0.02 M phosphate buffer (pH = 7.4); 80% human plasma and 10% rat liver homogenate. The results indicate higher chemical stability of the ester prodrugs in non-enzymatic SGF (t(1/2) congruent to 6.5-18.6 h) and rapid conversion to the parent drugs in 80% human plasma (t1/2 congruent to 11.4-235 min) as well as in 10% rat liver homogenates (t(1/2) congruent to 12.0-90.0 min). As a general pattern, the HMSI esters 5a-d revealed higher chemical stability than the corresponding HMIS analogues 6a-d. The pH-rate profile of 5c and 6a indicated maximum stability of the former at pH = 1.2-8.0 and of the latter at pH = 1.2-4.0. The distribution coefficient (D-7.4) values of the prodrugs 5a-d, 6a-d and the parent drugs 1a-d in an n-octanol/phosphate buffer (pH =7.4) system indicated enhanced lipophilic properties of the prodrugs. Furthermore, the HMIS ester prodrugs 6a-d are more lipophilic than the corresponding HMSI derivatives 5a-d. In vivo ulcerogenicity studies using scanning electron microscopy on stomach specimens of rats treated with an oral dose for 4 d revealed that the synthesized ester prodrugs are significantly less irritating to gastric mucosa than the parent drugs. These results suggested HMSI and/or HMIS esters possess good potential as prodrugs with an improved therapeutic index for oral delivery of NSAIDs. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐